VIRMA and ovarian cancer: SPI1, the key transcription factor regulating KIAA1429, forms a SPI1–KIAA1429–ENO1 axis that drives metabolic reprogramming, connecting m6A-mediated epigenetic changes to TME remodeling and ovarian cancer aggressiveness [72].